威尔药业(603351.SH)：前三季度净利润1.14亿元，同比增长1.03%

Core Insights - Will Pharmaceutical (603351.SH) reported a total operating revenue of 1.018 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 1.79% [1] - The net profit attributable to shareholders of the parent company reached 114 million yuan, showing a year-on-year increase of 1.03% [1] - The basic earnings per share stood at 0.84 yuan [1]